Allianz Asset Management Gmb H Alaunos Therapeutics, Inc. Transaction History

Allianz Asset Management Gmb H

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$2.09 - $3.09 $22,074 - $32,636	-10,562 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$2.39 - $3.43 $17,380 - $24,942	-7,272 Reduced 40.78%	10,562 $27,000
Q2 2020 Aug 14, 2020	SELL	$2.2 - $3.71 $416,878 - $703,007	-189,490 Reduced 91.4%	17,834 $58,000
Q1 2020 May 14, 2020	BUY	$1.9 - $4.98 $2,929 - $7,679	1,542 Added 0.75%	207,324 $508,000
Q4 2019 Feb 13, 2020	BUY	$3.95 - $5.35 $37,299 - $50,520	9,443 Added 4.81%	205,782 $971,000
Q3 2019 Nov 13, 2019	BUY	$4.13 - $6.94 $810,880 - $1.36 Million	196,339 New	196,339 $840,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $443M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.